Nonalcoholic fatty liver disease (NAFLD) and its progressive form ... the pathogenesis of NAFLD and the current treatment and management of nonalcoholic steatohepatitis. Currently, maintaining ...

Some of the key participants present in the global Cirrhosis Management market include Theravance Biopharma R&D, Alliancells Bioscience Corporation Limited, B. Braun Medical Inc., Conatus ...

The severity of HBV cirrhosis can be determined by periodic clinical examination and measurement of serum albumin, bilirubin, and prothrombin time. The Child-Turcotte-Pugh (CTP) score and Model ...

The liver, serving as the body's natural filtration system, faces significant challenges from alcohol consumption. As this ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

Besides weight loss, exercise can aid in reducing liver fat, improving inflammation biomarkers, and enhancing cardiovascular ...

MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a chronic liver disease that occurs when fat builds ...

L iver cirrhosis is a late-stage liver disease characterized by the gradual replacement of healthy liver tissue with scar tissue. This condition typically results from long-term chronic hepatitis ...

A Cleveland Clinic liver specialist discusses life expectancy with fatty liver disease and provides tips to take charge of your health.

Health-related quality of life is low among patients with ALD due to comorbidities, such as COPD and musculoskeletal and psychiatric disease.

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously called non-alcoholic fatty liver disease, is a ...

A live webcast of the Company presentation will be available through the investor relations section of the Company's website at www.akerotx.com. Following the live webcast, an archived replay will be ...